Glucose control and vascular complications in veterans with type 2 diabetes

Duckworth, William, Abraira, Carlos, Moritz, Thomas, Reda, Domenic, Emanuele, Nicholas, Reaven, Peter D., Zieve, Franklin J., Marks, Jennifer +8 more·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0808431

Cited by (1,057)

Items 601–700 of 1,057

Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients
Habib Yaribeygi, Alexandra E. Butler, George Emilio Barreto, Amirhossein Sahebkar · 2018 · Journal of Cellular Physiology
A Model for Predicting the Resolution of Type 2 Diabetes in Severely Obese Subjects Following Roux-en Y Gastric Bypass Surgery
Mark Thomas Hayes, Lynette Hunt, Jonathan Foo, Yulia Tychinskaya, Richard Strawson Stubbs · 2011 · Obesity Surgery
Do Veterans Health Administration Enrollees Generalize to Other Populations?
Edwin S. Wong, Virginia Wang, Chuan‐Fen Liu, Paul L. Hebert, Matthew L. Maciejewski · 2015 · Medical Care Research and Review
Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c
Xixiang Tang, Suhua Li, Yina Wang, Manman Wang, Qiongli Yin, Panwei Mu, Shuo Lin, Xiaoxian Qian, Xiaoming Ye, Yanming Chen · 2016 · Clinica Chimica Acta
Cerebrovascular complications of diabetes: focus on cognitive dysfunction
Trevor Hardigan, Rebecca Ward, Adviye Ergul · 2016 · Clinical Science
Classification and Diagnosis of Diabetes
SAUL M. GENUTH, Jerry P. Palmer, David M. Nathan · 2018
Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
Harold E. Lebovitz · 2011 · Diabetes Care
Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes
Franco Luigi Cavalot · 2013 · Diabetes Obesity and Metabolism
Impact of Hypoglycemia Associated With Antihyperglycemic Medications on Vascular Risks in Veterans With Type 2 Diabetes
Yingnan Zhao, Claudia R. Campbell, Vivian Andrew Fonseca, Lizheng Shi · 2012 · Diabetes Care
Cognitive dysfunctions in individuals with diabetes mellitus
Hye-Geum Kim · 2019 · Journal of Yeungnam Medical Science
Spectroscopy and molecular docking analysis reveal structural specificity of flavonoids in the inhibition of α-glucosidase activity
Jianli Liu, Yuchi Kong, Jingyi Miao, Xueying Mei, Shuyao Wu, Yichen Yan, Xiangyu Cao · 2019 · International Journal of Biological Macromolecules
Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
Anderson, Robert J., Bahn, Gideon D., Moritz, Thomas E., Kaufman, Derrick, Abraira, Carlos, Duckworth, William, for the VADT Study Group · 2011 · Diabetes Care
Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes
Ueki, Kohjiro, Sasako, Takayoshi, Okazaki, Yukiko, Miyake, Kana, Nangaku, Masaomi, Ohashi, Yasuo, Noda, Mitsuhiko, Kadowaki, Takashi · 2021 · Kidney International
Tratamiento de la diabetes tipo 2 en el paciente anciano
Ricardo Gómez‐Huelgas, Javier Díez‐Espino, Francesç Formiga, Javier Lafita Tejedor, Leocadio Rodríguez‐Mañas, Enrique González-Sarmiento, Edelmiro Luis Menéndez Torre, Javier Sangrós · 2012 · Medicina Clínica
Cardiovascular effects of the DPP-4 inhibitors
Tessey Jose, Silvio E. Inzucchi · 2012 · Diabetes and Vascular Disease Research
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Lim, Lee-Ling, Chow, Elaine, Chan, Juliana C. N. · 2023 · Nature Reviews Endocrinology
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
for the VADT Study Group, Agrawal, Lily, Azad, Nasrin, Bahn, Gideon D., Ge, Ling, Reaven, Peter D., Hayward, Rodney A., Reda, Domenic J., Emanuele, Nicholas V. · 2018 · Diabetologia
Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
M Hanefeld, E D Dütting, Peter Bramlage · 2013 · Cardiovascular Diabetology
American Geriatrics Society Identifies Another Five Things That Healthcare Providers and Patients Should Question
AGS Choosing Wisely Workgroup · 2014 · Journal of the American Geriatrics Society
Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
Robert A. Gabbay, Debbie Kendall, Christine Beebe, John K. Cuddeback, Todd M. Hobbs, Naeem D. Khan, Sandra Leal, Eden M Miller, Lucia M. Novak, Swapnil N. Rajpathak et al. · 2020 · Clinical Diabetes
New strategies to improve clinical outcomes for diabetic kidney disease
Thomas M. Forst, Chantal Mathieu, Francesco Giorgino, David Collins. Wheeler, Νικόλαος Παπάνας, Roland Erich Schmieder, Atef Halabi, Oliver Schnell, Marina Streckbein, Katherine R. Tuttle · 2022 · BMC Medicine
Hormones and Aging: An Endocrine Society Scientific Statement
Anne Rentoumis Cappola, Richard Joseph Auchus, Ghada El‐Hajj Fuleihan, David J. Handelsman, Rita Rastogi Kalyani, Michael R. McClung, Cynthia A. Stuenkel, Michael O. Thorner, Joseph George Verbalis · 2023 · The Journal of Clinical Endocrinology & Metabolism
The new biology of diabetes
Utpal B. Pajvani, Domenico Accili · 2015 · Diabetologia
The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis
Basem M. Mishriky, Doyle M. Cummings, Robert J. Tanenberg · 2015 · Diabetes Research and Clinical Practice
DPP-4 inhibitors: What may be the clinical differentiators?
John E. Gerich · 2010 · Diabetes Research and Clinical Practice
Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: Comparison by prevalent cardiovascular disease status
Nathan D. Wong, Christopher Patao, Kalina Wong, Shaista Malik, Stanley S. Franklin, Uchenna H. Iloeje · 2013 · Diabetes and Vascular Disease Research
Sodium‐glucose co‐transporter type‐2 inhibitors: pharmacology and peri‐operative considerations
David A. Milder, Tamara Y. Milder, Peter C. A. Kam · 2018 · Anaesthesia
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
Seyed Ebrahim Kassaian, Hamidreza Goodarzynejad, Mohammad Ali Boroumand, Mojtaba Salarifar, Farzad Masoudkabir, Mohammad Reza Mohajeri‐Tehrani, Hamidreza Pourhosseini, Saeed Sadeghian, Narges Ramezanpour, Mohammad Alidoosti et al. · 2012 · Cardiovascular Diabetology
Association between hypoglycemia and dementia in patients with type 2 diabetes
Yi‐Jing Sheen, Wayne Huey‐Herng Sheu · 2016 · Diabetes Research and Clinical Practice
Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
Saremi, Aramesh, Howell, Scott, Schwenke, Dawn C., Bahn, Gideon, Beisswenger, Paul J., Reaven, Peter D., for the VADT Investigators · 2017 · Diabetes Care
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
Lavanya Athithan, Gaurav Singh Gulsin, Gerry Patrick McCann, Eylem Levelt · 2019 · World Journal of Diabetes
Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes
David E. Kloecker, Melanie Jane Davies, Kamlesh Khunti, Francesco Zaccardi · 2020 · Annals of Internal Medicine
Mechanisms of diabetic kidney disease and established and emerging treatments
Victor Martinez Leon, Rachel Hilburg, Katalin Suszták · 2025 · Nature Reviews Endocrinology
Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.
Espen Jimenez‐Solem, Mette H Rasmussen, Mikkel Christensen, Filip Krag Knop · 2010 · PubMed
Evidence-Informed Guidelines for Treating Frail Older Adults With Type 2 Diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) Program
Laurie Herzig Mallery, Tom Ransom, Brian Steeves, Brenda Cook, Peggy Dunbar, Paige A. Moorhouse · 2013 · Journal of the American Medical Directors Association
Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: A move towards a unified glucose tetrad concept
Monnier, Louis, Colette, Claude, Owens, David R. · 2009 · Diabetes/Metabolism Research and Reviews
Glycemic Management in ESRD and Earlier Stages of CKD
Mark E. Williams, Rajesh Garg · 2014 · American Journal of Kidney Diseases
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus
Marian Sue Kirkman, Hussain Mahmud, Mary T. Korytkowski · 2018 · Endocrinology and Metabolism Clinics of North America
Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory
Sho‐ichi Yamagishi, Nobutaka Nakamura, Takanori Matsui · 2016 · Journal of Diabetes
Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies
Schnell, Oliver, Alawi, Hasan, Battelino, Tadej, Ceriello, Antonio, Diem, Peter, Felton, Anne-Marie, Grzeszczak, Wladyslaw, Harno, Kari, Kempler, Peter, Satman, Ilhan et al. · 2013 · Journal of Diabetes Science and Technology
Diabetes and Cardiovascular Disease: an Update
Almourani, Rajaa, Chinnakotla, Bhavana, Patel, Richa, Kurukulasuriya, L. Romayne, Sowers, James · 2019 · Current Diabetes Reports
Evidence‐based diabetes care for older people with Type 2 diabetes: a critical review
Alan J. Sinclair, Ahmed H. Abdelhafiz, Angus Forbes, Medha N. Munshi · 2018 · Diabetic Medicine
Atherogenic dyslipidemia and diabetic nephropathy
Giuseppina Tiziana Russo, Pamela Angela Piscitelli, Annalisa Giandalia, Francesca Chiara Viazzi, Roberto Pontremoli, Paola Fioretto, Salvatore De Cosmo · 2020 · Journal of Nephrology
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung Oh · 2023 · Diabetes & Metabolism Journal
Postprandial and Basal Glucose in Type 2 Diabetes: Assessment and Respective Impacts
Louis Monnier, C Colette, David R. Owens · 2011 · Diabetes Technology & Therapeutics
The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
Joel D. Schilling · 2015 · Antioxidants and Redox Signaling
The glycemic triumvirate and diabetic complications: Is the whole greater than the sum of its component parts?
L. Monnier, C Colette, David Owens · 2011 · Diabetes Research and Clinical Practice
Lowering Plasma 1-Deoxysphingolipids Improves Neuropathy in Diabetic Rats
Alaa Othman, Roberto Bianchi, Irina Alecu, Wei Yu, Carla Porretta‐Serapiglia, Raffaella Lombardi, A Chiorazzi, C Meregalli, N Oggioni, Guido Cavaletti et al. · 2014 · Diabetes
Association Between Severe Hypoglycemia, Adverse Macrovascular Events, and Inflammation in the Edinburgh Type 2 Diabetes Study
Bedenis, Rachel, Price, Anna H., Robertson, Christine M., Morling, Jo R., Frier, Brian M., Strachan, Mark W.J., Price, Jackie F. · 2014 · Diabetes Care
13. Older Adults: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A., Briggs Early, Kathaleen, ChallaSivaKanaka, Sathyavathi et al. · 2026 · Diabetes Care
Trends in Antidiabetic Prescription Patterns in Japan From 2005 to 2011
Takahide Kohro, Tsutomu Yamazaki, Hiroki Sato, Kenji Harada, Kazuhiko Ohe, Issei Komuro, Ryozo Nagai · 2013 · International Heart Journal
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito · 2018 · Journal of Endocrinological Investigation
Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus
Nikhil Tandon, Mohammed Kumail Ali, K.M. Venkat Narayan · 2012 · American Journal of Cardiovascular Drugs
Microalbuminuria: A parameter that has changed diabetes care
Hans‐Henrik Parving, Frederik Persson, Peter R Rossing · 2014 · Diabetes Research and Clinical Practice
High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization
Shipra Arya, Zachary O. Binney, Anjali Khakharia, Chandler A. Long, Luke Packard Brewster, Peter W.F. Wilson, William D. Jordan, Yazan M. Duwayri · 2017 · Journal of Vascular Surgery
Novel Approach to Non-Invasive Blood Glucose Monitoring Based on Transmittance and Refraction of Visible Laser Light
Haider Ali, Fayçal Bensaali, Fadi T. Jaber · 2017 · IEEE Access
Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease
Caroline A. Gluck, Chengxiang Qiu, Sang Youb Han, Matthew Palmer, Jihwan Park, Yi-An Ko, Yuting Guan, Xin Sheng, Robert L. Hanson, Jing Yang Huang et al. · 2019 · Nature Communications
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
João Victor da Silva Guerra, Marieli M. G. Dias, Anna Julyana Viana Chianca Brilhante, Maiara Ferreira Terra, Marta García‐Arévalo, Ana Carolina Migliorini Figueira · 2021 · Nutrients
A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
Chang Hee Jung, Jung Eun Jang, Joong‐Yeol Park · 2014 · Diabetes & Metabolism Journal
Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes
Catherine R. Mikus, Douglas J. Oberlin, Jessica L. Libla, L. J. Boyle, John P. Thyfault · 2012 · Diabetologia
Predictors of Development and Progression of Retinopathy in Patients with Type 2 Diabetes: Importance of Blood Pressure Parameters
Claudia R.L. Cardoso, Nathalie Carvalho Leite, Eduardo Dib, Gil Fernando Salles · 2017 · Scientific Reports
Glycaemic control for people with type 2 diabetes in Saudi Arabia – an urgent need for a review of management plan
Mohammed J. Alramadan, Dianna J. Magliano, Turky H. Almigbal, Mohammed Ali Batais, Afsana Afroz, Hesham J. Alramadhan, Waad Faozi Mahfoud, Adel Mehmas Alragas, Baki Billah · 2018 · BMC Endocrine Disorders
Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk
Francesco Giorgino, Jiten P Vora, Peter Fenici, Anna Solini · 2020 · Cardiovascular Diabetology
Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?
Douglas R. Farrell, Joseph A. Vassalotti · 2024 · BMC Nephrology
Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis
Yao Z. Liu, Yanmin Yang, Jun Zhu, Huiqiong Tan, Yan Liang, Jiandong Li · 2011 · Cardiovascular Diabetology
Current management of diabetes mellitus and future directions in care
Sudesna Chatterjee, Melanie Jane Davies · 2015 · Postgraduate Medical Journal
Diabetes and Risk of Arterial Stiffness: A Mendelian Randomization Analysis
Min Xu, Ya Fang Huang, Lan Xie, Kui Peng, Lin Ding, Lin Lin, Wang Po, Mingli Hao, Yuhong Chen, Yimin Sun et al. · 2016 · Diabetes
The effect of saffron (Crocus sativus L.) hydroalcoholic extract on metabolic control in type 2 diabetes mellitus: A triple-blinded randomized clinical trial
Abolghassem Djazayeri, Shahin Akhondzadeh, Alireza Milajerdi, Shima Jazayeri, Najmeh Hashemzadeh, Elham Shirzadi, Zhaleh Derakhshan · 2018 · Journal of Research in Medical Sciences
Diabetes and Peripheral Vascular Disease
Fabienne Huysman, Chantal Mathieu · 2009 · Acta chirurgica Belgica
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction
Marianne Benn, Anne Tybjærg‐Hansen, Mark I. McCarthy, Gorm Boje Jensen, Peer Grande, Børge Grønne Nordestgaard · 2012 · Journal of the American College of Cardiology
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in Humans
Ahmed Iqbal, Lynne R. Prince, Peter Novodvorský, Alan Bernjak, Mark Roland Thomas, Lewis Birch, Danielle Lambert, Linda J. Kay, Fiona Wright, Ian Andrew Macdonald et al. · 2018 · The Journal of Clinical Endocrinology & Metabolism
Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study
Michelle L. Jacobs, Pamela S. Sherry, Leigh M. Taylor, Mary G. Amato, Gary R. Tataronis, Gary W. Cushing · 2012 · Journal of the American Pharmacists Association
Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
Paneni, Francesco, Lüscher, Thomas F. · 2017 · The American Journal of Cardiology
Cardiovascular Effects of Glucagonlike peptide–1 Agonists
Michael H. Davidson · 2011 · The American Journal of Cardiology
Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update
Gillian L. Booth, Lorraine Lucille Lipscombe, Sonia Butalia, Kaberi Dasgupta, Dean T. Eurich, Ronald Goldenberg, Nadia Khan, Lori MacCallum, Baiju R. Shah, Scot H. Simpson et al. · 2016 · Canadian Journal of Diabetes
Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study
Shang‐Feng Tsai, Chao‐Tung Yang, Wei-Ju Liu, Chia-Lin Lee · 2023 · EClinicalMedicine
Vascular Protection in Diabetic Stroke: Role of Matrix Metalloprotease-Dependent Vascular Remodeling
Mostafa M. Elgebaly, Roshini Prakash, Weiguo Li, Safia N. Ogbi, Maribeth H. Johnson, Erin M. Mezzetti, Susan C. Fagan, Adviye Ergul · 2010 · Journal of Cerebral Blood Flow & Metabolism
Neuropathy: The Crystal Ball for Cardiovascular Disease?
Aaron I. Vinik, Raelene E. Maser, Dan Ziegler · 2010 · Diabetes Care
Comparative effectiveness of incident oral antidiabetic drugs on kidney function
Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos Gabriel Grijalva, Harvey J. Murff, Talat Alp Ikizler, Marie R. Griffin · 2012 · Kidney International
Treatment of prediabetes
Mustafa Kanat, Ralph A. DeFronzo, Muhammad A Abdul‐Ghani · 2015 · World Journal of Diabetes
Endothelial cell–cardiomyocyte crosstalk in diabetic cardiomyopathy
Andrea Wan, Brian B. Rodrigues · 2016 · Cardiovascular Research
Target for Glycemic Control
Monnier, Louis, Colette, Claude · 2009 · Diabetes Care
Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1
Ghazaleh Behnammanesh, Giovanna L. Durante, Yash P. Khanna, Kelly J. Peyton, William Durante · 2020 · Redox Biology
The ADDITION-Cambridge trial protocol: a cluster – randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients
Justin Basile Echouffo-Tcheugui, Rebecca K. Simmons, Kate M Williams, R. S. Barling, Andrew Toby Prevost, Ann Louise Kinmonth, Nicholas J. Wareham, Simon J. Griffin · 2009 · BMC Public Health
The Early Treatment of Type 2 Diabetes
Richard E. Pratley · 2013 · The American Journal of Medicine
Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus
Masakazu Haneda, Yutaka Seino, Nobuya Inagaki, Kohei Kaku, Takashi Sasaki, Atsushi Fukatsu, Haruka Kakiuchi, Yuri A. Sato, Soichi Sakai, Yoshishige Samukawa · 2015 · Clinical Therapeutics
Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)
Masaya Sakamoto, Rimei Nishimura, Taiga Irako, Daisuke Tsujino, Kiyotaka Ando, Kazunori Utsunomiya · 2012 · Cardiovascular Diabetology
The trials and tribulations of determining HbA1c targets for diabetes mellitus
Klara Rachel Klein, John B. Buse · 2020 · Nature Reviews Endocrinology
Is Hyperglycemia a Cardiovascular Risk Factor?
Frank Pistrosch, Andrea Natali, M Hanefeld · 2011 · Diabetes Care
Management of Type 1 Diabetes in Older Adults
Ruban Dhaliwal, Ruth S. Weinstock · 2014 · Diabetes Spectrum
Intensive Glucose Control and Cardiovascular Outcomes in Type 2 Diabetes
MacIsaac, Richard J., Jerums, George · 2011 · Heart, Lung and Circulation
The economic burden of progressive chronic kidney disease among patients with type 2 diabetes
Suma X. Vupputuri, Teresa M. Kimes, Michael O. Calloway, Jennifer Briley Christian, David F. Bruhn, Alan A Martin, Gregory A. Nichols · 2013 · Journal of Diabetes and its Complications
Screening for Type 2 Diabetes and Dysglycemia
Justin Basile Echouffo-Tcheugui, Mohammed Kumail Ali, Simon J. Griffin, K.M. Venkat Narayan · 2011 · Epidemiologic Reviews
Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
Yehuda Handelsman · 2011 · Diabetes Care
Diabetes-related cardiomyopathy: the sweet story of glucose overload from epidemiology to cellular pathways
Joubert, M., Manrique, A., Cariou, B., Prieur, X. · 2019 · Diabetes & Metabolism
Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors
Lin, Donna Shu-Han, Lee, Jen-Kuang, Chen, Wen-Jone · 2021 · Diabetologia
Association between diabetes and prevalence and growth rate of abdominal aortic aneurysms: A meta-analysis
Jiang Xiong, Zhongyin Wu, Chen Chen, Y Q Wei, Wei Guo · 2016 · International Journal of Cardiology
(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
Semlitsch, Thomas, Engler, Jennifer, Siebenhofer, Andrea, Jeitler, Klaus, Berghold, Andrea, Horvath, Karl · 2020 · Cochrane Database of Systematic Reviews
Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes
Juraj Koška, Hertzel C. Gerstein, Paul J. Beisswenger, Peter D. Reaven · 2022 · Diabetes Care
Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study
Cheng‐Chieh Lin, Chun‐Pai Yang, Chia-Ing Li, Chiu-Shong Liu, Ching‐Chu Chen, Wen‐Yuan Lin, Kai-Lin Hwang, Sing-Yu Yang, Tsai‐Chung Li · 2014 · BMC Medicine